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Abstract
p16INK4a is a major tumor-suppressor protein, but its
regulation and settings of fuction remain poorly under-
stood. To explore the notion that p16 is induced in vivo
in response to replicative stress, we examined p16
expression in tissues from human ulcerative colitis
(UC; n = 25) and normal controls (n = 20). p16 was
expressed strongly in UC-associated neoplasms
(n = 17), as seen previously in sporadic colonic
neoplasms. In non-neoplastic UC epithelium, p16 was
expressed in 33% of crypts (the proliferative compart-
ment) compared to < 1% of normal controls. p16
expression did not correlate with degree of inflam-
mation but did correlate with the degree of crypt
architecture distortion (P = .002)—a reflection of epi-
thelial regeneration. In coimmunofluorescence studies
with Ki67, p16 expression was associated with cell
cycle arrest (P < .001). Both UC and normal crypts dis-
played evidence for the activation of the DNA dam-
age checkpoint pathway, and p16 was induced in
primary cultures of normal epithelial cells by ionizing
irradiation (IR). However, induction by IR displayed
delayed kinetics, implying that p16 is not an imme-
diate target of the checkpoint pathway. These find-
ings support a model in which p16 is induced as an
‘‘emergency brake’’ in cells experiencing sustained
replicative stress.
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Introduction
p16INK4a (p16) is a major tumor-suppressor protein, which is
inactivated with particular frequency in solid tumors of the
gastrointestinal epithelium [1–3]. The protein binds selec-
tively to cyclin-dependent kinases (Cdks) 4 and 6, and
inhibits the activity of these Cdks and Cdk2, the latter by
indirect means. Cdk inhibition prevents the phosphorylation
of retinoblastoma family proteins and fosters the repression
of E2F-regulated genes involved in cell replication. Mice
with engineered mutations in the p16 gene develop nor-
mally but are tumor-prone [4].
In contrast to our relatively sophisticated understanding of
its response pathway, the regulation of p16 remains poorly
understood. p16 is expressed at low to undetectable levels in
most normal tissues [5–8]. Ultraviolet light can stimulate p16
expression in skin keratinocytes [9,10]. p16 expression is also
commonly increased by tissue culture, but the physiologic
relevance of this observation has remained unclear [11]. The
in vivo settings in which p16 is induced and the steps during
neoplastic progression at which p16 intervenes are ill defined.
Genetic studies in mouse models suggest that p16 may con-
strain the long-term proliferation of bonemarrow stem cells [12].
p16 inactivation has been shown to occur early in some
gastrointestinal neoplasms [3]. Promoter methylation is a com-
mon mode of p16 inactivation in tumors and is thought to
be a relatively specific event, reflecting selection pressure.
p16 methylation is found in colon adenomas and carcinomas
[13–16] and in early neoplastic epithelium in Barrett esopha-
gus [17], in some colonic tissues of patients with longstanding
ulcerative colitis (UC) [18], and in some cells with preneoplastic
features in the mammary epithelium [19–21]. These observa-
tions suggest that p16 may be expressed and rate-limiting for
proliferation in settings of preneoplasia or early neoplasia.
We have demonstrated previously that p16 is induced in
sporadic carcinomas, adenomas, and aberrant crypt foci in the
colon [8]. We now extend these studies to UC—an important
preneoplastic disease of the colon that is characterized by
chronic epithelial damage and ulceration requiring epithelial
regeneration. We demonstrate distinct p16 induction within
regenerating crypts and neoplasia arising in this setting. These
findings suggest that p16 may regulate epithelial regeneration
in this context. Recent evidence suggests that DNA damage
may be prevalent in settings of early neoplasia and hyperplasia
[22,23]. We find evidence for DNA damage checkpoint activa-
tion in UC and in normal colon, and demonstrate that p16 is
Abbreviations: UC, ulcerative colitis; AD, architectural distortion
Address all correspondence to: Greg H. Enders, MD, PhD, Penn/GI Division, Suite 600/CRB,
415 Curie Boulevard, Philadelphia, PA 19104-6140. E-mail: endersgh@mail.med.upenn.edu
1This work was supported by National Institutes of Health (NIH) grant R01 DK6475801 (to
G.E.) and used the Morphology Core Facility of the NIH Center for Molecular Studies in
Digestive and Liver Diseases at the University of Pennsylvania (grant P30 DK50306).
Received 16 February 2006; Revised 5 April 2006; Accepted 6 April 2006.
Copyright D 2006 Neoplasia Press, Inc. All rights reserved 1522-8002/06/$25.00
DOI 10.1593/neo.06169
Neoplasia . Vol. 8, No. 6, June 2006, pp. 429 – 436 429
www.neoplasia.com
BRIEF ARTICLE
induced by ionizing radiation in diverse normal human epi-
thelial cells in culture, with delayed kinetics. Our findings
support a model in which brief replicative stress is insufficient
to induce p16, but in which sustained replicative stress may
be a common physiologic mediator of p16 induction, in both
non-neoplastic and neoplastic cells.
Materials and Methods
Tissue Collection and Histologic Grading
Colonic tissues from 25 UC cases and 20 normal controls
were obtained from specimens in the Department of Pathol-
ogy at the Hospital of the University of Pennsylvania. Ten UC
cases had associated polypoid dysplasia, six had associated
adenocarcinoma, and three had pseudopolyps. Formalin-
fixed paraffin-embedded sections were stained with hema-
toxylin and eosin and were examined under light microscopy.
The degrees of inflammation and crypt distortion, respec-
tively, were graded on a scale of 0 to 3, with 0 representing
normal features. For inflammation, (1 = neutrophils infiltrated
the mucosa in a spotty fashion; 2 = neutrophils infiltrated be-
tween one third and two thirds of the mucosa; 3 = neutrophils
infiltrated at least two thirds of the mucosa). Ulceration was
considered a marker of acute inflammation. Expansion of
the lamina propria by lymphocytes and/or plasma cells
was considered a marker of chronic inflammation. Crypt
distortion was scored when crypts deviated from their
normal straight, regular spacing. A grade of 1 was assigned
for branching and/or irregular spacing involving up to one
third of crypts, a grade of 2 was assigned for the involve-
ment of one third to two thirds of the crypts, and a grade of
3 was assigned for the involvement of two thirds or more of
the crypts. Dysplastic crypts with architecture distortion were
scored separately as dysplasia. Similar scoring schemes
for UC have been reported and correlated with clinical and
endoscopic findings [24].
Antibodies, Immunohistochemistry,
and Immunofluorescence
Expression of p16 was assessed in colonic tissues by
immunohistochemistry and immunofluorescence using the
mouse monoclonal antibody (mAb) JC2, which recognizes
the first ankyrin repeat of p16 [7,25]. p16 and Ki67 immuno-
histochemistry was performed by standard procedures on
formalin-fixed paraffin-embedded sections with antigen re-
trieval (microwave treatment of slides immersed in citric acid
buffer), as previously described [8]. Immunohistochemical
staining of serine 1981–phosphorylated ataxia telangiec-
tasia mutated (ATM) was a performed on frozen sections
using rabbit antibody (Rockland, Gilbertsville, PA). For im-
munohistochemistry on cultured cells, cells were fixed and
permeabilized with acetone/methanol (1:1) for 10 minutes at
20jC, and processed without antigen retrieval. The avidin/
biotin detection system (Vector Laboratories, Burlingame,
CA) was used with light hematoxylin counterstaining. Ki67
was detected using rabbit antibody (Novocastra Labora-
tories Ltd., New Castle upon Tyne, UK). Secondary anti-
bodies for immunofluorescence were a CY2-labeled donkey
anti-mouse antibody (Jackson ImmunoResearch Laborato-
ries, West Grove, PA) and a CY3-labeled donkey anti-
rabbit antibody (Jackson ImmunoResearch Laboratories).
For simultaneous detection of p16 and Ki67 by coimmuno-
fluorescence, CY2 and CY3 signals were collected by sep-
arate filters and combined using IPLab Spectrum software
(Scanalytics, Fairfax, VA). All cells with staining clearly
above background were scored as positive.
Cell Culture and Ionizing Irradiation (IR)
Normal human esophageal epithelial cells were isolated,
as previously described [26], from excess human clinical
tissues, according to a protocol approved by the institutional
review board. Normal primary human bronchial and pros-
tate epithelial cells at passages 3 to 5 were purchased from
Clonetics/Biowhittaker (nowCambrex,Walkersville, MD) and
cultured under their specifications. Cells were irradiated with
8 Gy using a J. L. Shepard Model 30 Mark l 137Cs irradiator.
Immunoblotting, Northern Blot Analysis,
and Flow Cytometry
Immunoblotting [8], Northern blot analysis [27], and flow
cytometry [27] were performed as previously described.
Northern blot analysis used a probe generated by poly-
merase chain reaction from p16 exon 1a.
Results
We examined p16 expression by immunohistochemistry
using the highly sensitive and specific mAb, JC2 [7,8,25].
Immunohistochemical staining with this antibody has been
validated by Western blot analysis and reverse transcription–
polymerase chain reaction [8]. Thirty-three specimens from
25 patients with UC were examined together with 20 normal
controls. Among the UC cases, 10 had polypoid dysplasia,
6 had carcinoma, and 3 had pseudopolyps.
We observed dramatically higher p16 expression in the
non-neoplastic epithelium of UC specimens (Figure 1). Thirty-
three percent of UC crypts displayed p16 staining versus less
than 1% of crypts from normal controls. (Figure 2, A–C). p16
expression was most prominent in crypts with greater archi-
tectural distortion (AD) (Figure 2, D–F ). Two percent of crypts
in patients without AD displayed p16 staining, compared with
about 30% of crypts with mild to moderate AD and with 60%
of crypts with severe AD (Figure 2F ). The Spearman correla-
tion coefficient for this relationship was highly significant
(R = 0.573, P = .002). In contrast, there was no correlation
between p16 staining and degree of acute/chronic inflamma-
tion (data not shown). p16 staining was further elevated in
dysplasia (Figure 2,G andH ). Ninety-one percent of dysplasia
specimens and all six carcinomas evidenced distinct p16
staining. The staining in these lesions was heterogeneous,
with marked differences in intensity between adjacent cells.
This pattern is consistent with our previous findings in sporadic
colonic neoplasia [8].
We performed coimmunofluorescence studies using the
robust proliferation marker Ki67 [28–30]. p16 staining was
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inversely associated with Ki67 staining in UC samples
(P < .001; Figure 3). As seen by immunohistochemistry,
p16-positive staining often appeared to be confined to the
lower portion of the crypt (Figure 3C), although this assess-
ment can be difficult in the presence of crypt AD. These
results suggest that, at least at higher levels detectable by
immunofluorescence, p16 expression is associated with cell
cycle arrest.
Recent evidence suggests that early neoplasia and hy-
perplasia are often accompanied by DNA damage [22,23].
Induction of p53 and p21 has recently been observed in
some UC mucosae, in the absence of detectable p53 muta-
tion [31]. These proteins are well-characterized components
of DNA damage response, although not specific for it.
Furthermore, UV light can induce p16 in skin keratinocytes
[10]. We therefore examined UC tissue for evidence of DNA
damage checkpoint activation. UC crypts, as well as those
from the normal colon, bound an antibody specific for ATM
phosphorylated on serine 1981—a marker of ATM activation
[32] (Figure 4A). Staining intensity was not dramatically
different in UC versus normal samples. We obtained similar
results following staining with an antibody directed against
another marker of DNA damage checkpoint activation, phos-
phorylated histone H2AX (data not shown) [22,23]. We
reasoned that a brief period of replicative stress in normal
colonic transit-amplifying cells might not be sufficient to
induce p16, in contrast to a sustained period of replicative
stress that occurs while stem cells and/or transit-amplifying
cells repopulate denuded mucosae. To assess more directly
whether replicative stress can induce p16, we tested whether
p16 can be induced in human epithelial cells by IR, the
prototype mediator of DNA double-strand breaks. Colonic
epithelial cells cannot be cultured under standard conditions
[33], and nearly all established colon cell lines have demon-
strable lesions in the p16/Rb pathway [34]. We therefore
examined p16 expression in several representative primary
human epithelial cells amenable to tissue culture. Immuno-
histochemistry and immunoblotting demonstrated that IR
induced p16 in each epithelial cell type tested (bronchi,
prostate, and esophagus) (Figure 4, B and C). Induction
was not immediate, but required several days to become
manifest (Figure 4C) and also appeared to require sustained
cell proliferation (data not shown). Northern blot analysis
pointed to induction at the mRNA level (Figure 4D). Dual
immunofluorescence staining with incorporated BrdU [27]
showed that most p16-expressing cells were arrested (data
not shown). Flow cytometry demonstrated that most cells
were arrested in G1 phase (the typical phase of a p16-
mediated arrest; Figure 4E ), as opposed to the G2 phase
arrest commonly observed following IR treatment of trans-
formed cell types [35].
Discussion
We found that p16 is induced in crypts of patients with UC.
Induction correlated with degree of crypt AD, rather than with
inflammation, implying that epithelial regeneration under
stress may be a key factor. p16 expression is generally low
in most normal tissues, including the colon [7]. Increased p16
expression has been observed in a number of tumor types,
Figure 1. p16 induction in UC. Normal (Nl) (A and C) and UC (B and D) mucosal samples were stained with hematoxylin and eosin (A and B) or with an antibody
directed against p16 (C and D). Note the absence of brown reaction product indicative of p16 staining in the normal colon (C) and the presence of p16 staining in
intestinal epithelial crypts in UC (D). Original magnification, 10 to 20.
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including those from the colon [8], breast [36], endometrium
[37], and pancreas [38], and in some aging tissues [5,6], but
has rarely been observed in non-neoplastic diseases. Our
results underscore that a neoplastic state is not necessary
for p16 induction in vivo. The finding that p16 is induced in
the proliferative compartment of regenerating epithelium
Figure 2. p16 induction in UC in isolated crypts, areas of marked AD, and dysplasia. p16 staining in isolated crypts (A–C), areas of marked crypt AD (D and E), and
dysplasia (G and H). Original magnification, 10 to 20. (F) The degree of crypt AD in each patient sample (n = 26) was scored on a scale from 0 (none) to 3 (high)
(0, n = 3; 1, n = 5; 2, n = 4; 3, n = 14). The percentage of crypts in each sample that was positive for p16 was scored and graphed. Spearman correlation coefficient
(q) = 0.57 for trend (P = .002, two-sided).
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suggests that proliferative stress can induce p16 in vivo and
in vitro. Furthermore, we found that ionizing radiation in-
duces p16 expression in diverse normal cultured human
epithelial cell types, with delayed kinetics. These results pro-
vide further evidence that replicative stress and potential
DNA damage per se can incite p16 induction.
p16 is induced in a variety of primary mammalian cells in
response to culture stress and limits the long-term prolifer-
ation of cultured cells [1,39,40]. Whether or not this induction
is artifactual has been controversial [11]. Induction of p16
appears to be governed, in part, by the Ets2 transcription
factor, with augmentation by Ras pathway signaling [41] and
JunB [42]. Recent surveys of expression in aging mice
suggest that these factors likely account for some, but not
all, of the normal tissue- and age-related differences in p16
expression [6]. Our findings strengthen evidence that p16
acts as a brake on the proliferation of cells experiencing
physiologic levels of replicative stress in vivo.
Evidence for p16 involvement in cell cycle inhibition fol-
lowing DNA damage has previously emerged. p16 is known
to be induced by UV light in primary human skin keratino-
cytes [10,43]. In addition, p16 contributes to G1 arrest
following IR in human fibroblasts [44]. p16 was not found
to be induced in that study [44], but was noted to increase
during the weeks following the treatment of fibroblasts with
the DNA-damaging agent, bleomycin [45]. Recent demon-
stration that preneoplastic and early neoplastic states are
commonly characterized by ongoing DNA damage [22,23]
and that increased Cdk activity per se can mediate DNA
damage [23] points to a potential stimulus for p16 induction
in UC. Furthermore, an independent but less extensive study
of p16 expression in UC revealed evidence for coexpression
in some tissues with p21 and p53, without detected p53
mutation [31]. The absence of p53 mutations suggests that
the p53 induction observed is not due to the stabilization of
inactive p53, but may reflect functional induction by DNA
damage or other stimuli. These authors surmised that the
increase in p16 in such settings might be due to feedback
regulation by the p53 pathway. However, the potential mech-
anism here is unclear, and skin cell lines with mutant p53
have been found to induce p16 following UV treatment [9].
We suggest instead that DNA damage may be acting as a
common inducer of p53 and p16 in UC. Further investigation
will be required to identify the factors regulating p16 expres-
sion following DNA damage and to determine whether DNA
damage checkpoint pathways are involved. The relatively
gradual induction of p16 after IR suggests that this induc-
tion may involve additional factors beyond the immediate
checkpoint response. Factors such as stem cell phenotype,
sustained proliferation, or quantitative differences in DNA
Figure 3. Paucity of Ki67 staining in p16-expressing UC cells. Samples from three patients identified as p16-positive by immunohistochemistry were assayed by
coimmunofluorescence for p16 (green) and Ki67 (red). Nuclei are identified by DAPI staining (blue). (A) Triple-color merged image. Sheets of epithelium are readily
identifiable by tightly packed, basally oriented DAPI-stained nuclei. Note the absence of red staining in the nuclei of green-stained cells. (B and C) Two-color
merged green and red images. Note that epithelial cells are either red or green, whereas scattered apoptotic mesenchymal cells bind both antibodies
nonspecifically and stain yellow. In (C), crypts are outlined by white lines. Note that, in the large crypt with a visible lumen (bottom right), p16-positive cells appear to
be located near the base. In addition, the crypt with five p16-positive cells in (A) has both a narrow lumen and a small overall diameter, suggesting that it is near the
base. (D) Graph illustrating low Ki67 positivity in p16-positive cells. A total of 1299 cells from 9  20 fields were scored. The mean percent Ki67-positive cells per
field ± SD were graphed (P < .001; two-tailed t-test). Original magnification, 20.
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damage may account for preferential induction in the UC
epithelium versus the normal epithelium. We envision that
p16 induction in the setting of replicative stress acts to re-
duce the number of stressed cells and their proliferation
rates, thereby reducing the propensity for genetic change
leading to neoplasia and for paracrine signaling by stressed
cells. Sustained induction in this setting may mediate cellular
senescence [46,47].
Our data suggest that p16 expression in UC likely con-
strains the proliferation of the principal constituents of crypts,
colonic stem cells, and/or their highly proliferative progeny,
the transit-amplifying cells [48,49]. There are potential paral-
lels in other tissues. Bmi1 has been implicated as a tran-
scriptional repressor of p16 [50,51]. Bmi1 is preferentially
expressed in primitive stem cells of the hematopoietic sys-
tem, and Bmi1-null mice die of bone marrow failure. Adoptive
transfer experiments point to a deficiency of bone marrow
stem cells with long-term proliferative potential [50]. Prolifer-
ative defect is partially rescued by deletion of the Ink4/Arf
locus, implying that p16 may limit the proliferation of bone
Figure 4. p16 is induced in the setting of DNA damage. (A) Immunohistochemical staining for ATM phosphorylated on serine 1981 in representative frozen sections
of normal (Nl; n = 6) and UC (n = 6) colon. Arrows mark nuclear staining (brown) that is particularly prominent at the base of crypts. Left to right: ca. 20, 20, 40,
and 60 images. No staining was observed in adjacent tissue sections stained without primary antibody (not shown). (B) Early passage bronchial epithelial cells
(BEC) and esophageal epithelial cells (EEC) were irradiated with 8 Gy (IR) or were left untreated (con), fixed 6 days later, and subjected to immunohistochemistry
for p16 (brown stain). Staining was also performed with a mouse mAb directed against a fungal toxin as negative control (con Ab). Note that some unirradiated cells
express detectable p16, as is typically observed in primary cells, and that many irradiated cells develop a flattened senescent morphology (all images, ca. 20). (C)
Immunoblotting was performed for p16 before (0) and 3 and 6 days after IR in BEC and prostate epithelial cells (PEC). Extensively passaged mammary epithelia
cells typically sustain p16 promoter methylation [52] and serve as negative control (C). U2-OS cells engineered to induce p16 [27] served as positive control (+C).
Load: Coomasie-stained protein. (D) Northern blot analysis of mRNA 3 days after IR in EEC demonstrated increased p16 mRNA. RNA from SaOS2 (+C) and U2-
OS (C) cells served as positive and negative controls, respectively. The same blot was stripped and reprobed for actin, as loading control. (E) EEC cell cycle
arrest in G1 and G2/M following IR. EEC were left untreated (con) or were harvested 4 days after IR and analyzed for DNA content by flow cytometry. The
percentages of cells in each cell cycle phase are noted. Note that the S-phase fraction was nearly abolished in the IR-treated sample, indicating that few cells were
cycling, whereas 63% of the cells remained in G1 phase.
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marrow stem cells. One model to unify these observations
and the marked heterogeneity of p16 expression in colonic
neoplasms [8,31] would be for p16 to constrain the prolifera-
tion of cells experiencing sustained proliferative stress, in
each setting.
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